Analyst Models $75-Per-Share Buyout
Private equity giant KKR reportedly expressed interest in buying out Walgreens, and JPMorgan analyst Lisa Gill is modeling a deal to take place at around $75 per share, or a 21% premium from current levels, according to Fox Business.
This would value the company at $85 billion based on a debt ratio of 6.5 times and other metrics.
Walgreens' Tough Q2
A takeout offer at $75 per share would also imply a price tag that is 15% below the stock's 52-week high of $86.31, which was recorded in early December, 2018.
Much has changed in Walgreens' business over the past year, including declining margins and a slowdown in sales amid growing competition from traditional pharmacies and new online channels.
Walgreens CEO Stefano Pessina said in the company's second-quarter report that it saw "market challenges and macro trends" in the quarter, according to Fox Business.
The CEO said it was the "most difficult quarter" since the combination with Europe's Alliance Boots created the new global drug and pharmacy store.
If reports are accurate, a leveraged buyout of Walgreens would become the largest of its kind in history.
The stock was up 0.14% at $62.16 at the time of publication Thursday.
12 Dow Stocks With At Least 2% Dividend Yields
Report: Walgreens Explores Going Private
Photo by MusikAnimal via Wikimedia.
Latest Ratings for WBA
View More Analyst Ratings for WBA
View the Latest Analyst Ratings
See more from Benzinga
- Cramer Praises Bob Iger On Historic Day For Disney+, Stock
- Is Softbank's Son Apology For Poor Investments Genuine Or Due To Pressure?
- Diplomat Pharmacy Analysts Weigh Takeout Scenarios, Valuation After Going Concern Warning
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.